The spine market continued to stabilize in the second quarter as NuVasive reported a 44.8 percent increase in second-quarter net sales compared to the same period last year.
Spinal Tech
NuVasive's Pulse platform for spine surgery received FDA 510(k) approval, and it is now available for sale.
Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.
Medical device company MirRus raised $65 million in a round of funding for its Rhenium-based spine devices and heart disease treatment development, the company said July 27.
Spine-facing medical technology company Carlsmed is collaborating with the International Spine Study Group Foundation to collect surgical data on personalized interbody devices.
Advertisement
NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, and clinical evaluations of its Pulse spine system got underway in Europe.
Stryker plans to hone in on smaller mergers and acquisitions as part of its strategy for short-term growth, according to CEO Kevin Lobo.
Degenerative disc disease patients who underwent total disc replacement with the ActivL Artificial Disc had better outcomes than patients who received the ProDisc-L, according to a study by Aesculap Implant Systems.
NuVasive's newest spine implant and four more updates from device companies in the last week:
Stryker posted $1.6 billion in net sales for its orthopedics business in the second quarter, and the company saw growth across all orthopedic procedure types.